Feb 18 () - Contract drug developer Charles River Laboratories on Wednesday forecast annual profit above Wall Street ...

Here are the latest biotech industry updates: introducing new platforms for SPR, RNA-seq libraries and DNA extraction.

AI boosts efficiency in early, high-failure R&D, improving success rates and capital efficiency across biotech and pharma.

Chinese pharmaceutical companies that as a group chalked up record outbound licensing agreements with international industry ...

Axol Bioscience Ltd. (Axol), a leading provider of induced pluripotent stem cell (iPSC) technologies for drug discovery and ...

Peptris plans on utilising the fresh capital to bolster its clinical readiness while also expanding its pipeline over the ...

Global drugmakers are stepping up their search for China‑developed experimental medicines as they cut costs ahead of patent ...

The FDA has opened the door to the use of Bayesian statistical methods in clinical trials. The worry: Introducing ...

LIXTE Biotechnology Holdings, Inc. ('LIXTE” or the 'Company”) (Nasdaq: LIXT), a clinical stage pharmaceutical and med-tech company focused on advancing cancer treatments, today announced it has ...

An eczema drug from Nektar Therapeutics maintained skin responses in a one-year study, meeting and in some cases exceeding ...

Discusses Integrated Prefillable Syringe Systems to Streamline Drug Development and Reduce Complexity February ...